Patient Corner

Anatomical Illustrations

More

Last reference updates

  • Aug 18, 2017 - FDA Drug Updates

FDA approves Besponsa (inotuzumab ozogamicin) for acute lymphoblastic leukemia

Besponsa (inotuzumab ozogamicin) is new targeted therapy for acute lymphoblastic leukemia

Read more
  • Aug 18, 2017 - MedWatch Drug Updates

Recall of lorazepam oral concentrate, USP 2mg/mL - defect in the dropper markings

Recall of lorazepam oral concentrate, USP 2mg/mL because of misprinted dosing droppers supplied with the product

Read more
  • Aug 14, 2017 - MedWatch Drug Updates

FDA safety alert: Potential complication associated with liquid-filled intragastric balloon systems

FDA update to health care providers on potential complication associated with liquid-filled intragastric balloon systems used to treat obesity.

Read more
  • Aug 14, 2017 - MedWatch Drug Updates

FDA Alert: Lack of sterility assurance for sterile drug products from Vital Rx, dba Atlantic Pharmacy and Compounding

Administration of a non-sterile product intended to be sterile may result in serious and potentially life threatening infections or death.

Read more
  • Aug 14, 2017 - MedWatch Drug Updates

Recall of all liquid products manufactured by PharmaTech: Risk of product contamination

Recall of all liquid products manufactured by PharmaTech and distributed by Leader Brand, Major Pharmaceuticals, and Rugby Laboratories due to risk of product contamination.

Read more
  • Aug 14, 2017 - MedWatch Drug Updates

Recall of pravastatin sodium tablets by International Laboratories: Mislabeled and contained different drug

Recall of pravastatin sodium tablets USP 40 mg by International Laboratories as it was mislabelled and contained bupropion hydrochloride XL 300 mg tablets.

Read more
  • Aug 9, 2017 - MedWatch Drug Updates

FDA advise not to use any liquid product manufactured by PharmaTech due to possible contamination

FDA urges do not use any liquid product manufactured by PharmaTech due to possible contamination with Burkholderia cepacia.

Read more
  • Aug 8, 2017 - MedWatch Drug Updates

FDA Investigation: Hypersensitivity reaction due to ungraded ingredient in curcumin emulsion for Injection by ImprimisRx

Hypersensitivity reaction with polyethylene glycol (PEG) 40 castor oil in curcumin emulsion product for Injection by ImprimisRx

Read more
  • Aug 8, 2017 - MedWatch Drug Updates

FDA warning against the use of Balguti Kesaria Ayurvedic Medicine due to risk of lead poisoning

Exposure to lead can cause serious damage to the central nervous system, the kidneys and the immune system.

Read more
  • Aug 4, 2017 - MedWatch Drug Updates

Recall of Diocto Liquid and Diocto Syrup by Rugby Laboratories: Risk of product contamination

Rugby Laboratories has recalled the Diocto Liquid and Diocto Syrup due to a risk of product contamination with Burkholderia cepacia

Read more